This is a Validated Antibody Database (VAD) review about bovine TP53, based on 47 published articles (read how Labome selects the articles), using TP53 antibody in all methods. It is aimed to help Labome visitors find the most suited TP53 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Abcam
mouse monoclonal (PAb 240)
  • western blot; human; 1:1000; loading ...; fig 4c
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples at 1:1000 (fig 4c). Leukemia (2022) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; loading ...; fig 3i
  • western blot; human; 1:1000; loading ...; fig 3h
Abcam TP53 antibody (Abcam, ab26) was used in western blot on mouse samples (fig 3i) and in western blot on human samples at 1:1000 (fig 3h). Cell Death Dis (2021) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; loading ...; fig 5b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on mouse samples (fig 5b). J Am Heart Assoc (2021) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 3j
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig 3j). Cancer Metab (2021) ncbi
mouse monoclonal (PAb 240)
  • immunoprecipitation; mouse; 1:100; loading ...
Abcam TP53 antibody (Abcam, ab26) was used in immunoprecipitation on mouse samples at 1:100. elife (2020) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:200; loading ...; fig 3f, 7b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on mouse samples at 1:200 (fig 3f, 7b). Aging (Albany NY) (2020) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig s3
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig s3). Int J Biol Sci (2019) ncbi
mouse monoclonal (PAb 240)
  • immunoprecipitation; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 1a, 1b
Abcam TP53 antibody (Abcam, ab26) was used in immunoprecipitation on human samples (fig 4a) and in western blot on human samples (fig 1a, 1b). Redox Biol (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; 1:1000; loading ...; fig s3b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples at 1:1000 (fig s3b). J Clin Invest (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:1000; loading ...; fig 1c
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples at 1:1000 (fig 1c). BMC Biotechnol (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 4b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 4b). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 5a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig 5a). J Mol Neurosci (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 6a
  • western blot; human; loading ...; fig 6a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 6a) and in western blot on human samples (fig 6a). Cancer Lett (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:1000; loading ...; fig 6c
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples at 1:1000 (fig 6c). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:500; loading ...; fig 2d
Abcam TP53 antibody (Abcam, Ab26) was used in western blot on mouse samples at 1:500 (fig 2d). Kidney Blood Press Res (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig s6
Abcam TP53 antibody (Abcam, Ab240) was used in western blot on human samples (fig s6). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (PAb 240)
  • immunocytochemistry; human; loading ...; fig s9
Abcam TP53 antibody (Abcam, 240) was used in immunocytochemistry on human samples (fig s9). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 2a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
Invitrogen
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; tbl 2
In order to review the relevance of BRAF V600E mutation to colorectal cancer, Invitrogen TP53 antibody (Thermo Fisher Scientific, D07) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). J Korean Med Sci (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to find prognostic clusters for breast cancer, Invitrogen TP53 antibody (NeoMarkers, DO7) was used in immunohistochemistry - paraffin section on human samples (fig 1). BMC Cancer (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; loading ...; fig 3c
In order to describe the mechanism behind the association between single nucleotide polymorphism rs55705857 and glioma development., Invitrogen TP53 antibody (Thermo Fisher, A00021-IFU) was used in immunohistochemistry on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:600; fig 1
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen TP53 antibody (Thermo, DO-7) was used in immunohistochemistry on human samples at 1:600 (fig 1). Diagn Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1b
In order to evaluate the diagnostic value of stathmin expression in samples of vulvar intraepithelial neoplastic lesions, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1b). J Clin Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:1000; tbl 2
In order to perform morphological, p53 immunohistochemical, and TP53 gene mutational analyses of pelvic carcinosarcomas, Invitrogen TP53 antibody (Thermo Fisher, DO-7) was used in immunohistochemistry on human samples at 1:1000 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 4
In order to study APC/C(Cdh1) function, Invitrogen TP53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 4). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 1b
In order to develop a method to examine protein oligomerization in cells using a single electrophoresis gel, Invitrogen TP53 antibody (Thermo Fisher, DO-7) was used in western blot on human samples (fig 1b). Anal Bioanal Chem (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 8
In order to assess links between telomere-dysfunction and centrosome defects in early breast carcinogenesis, Invitrogen TP53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen TP53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Pathol Res Pract (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:400
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on human samples at 1:400. Gynecol Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 1
In order to report that p53 and DeltaNp63alpha are transcriptional partners for SMAD proteins, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in western blot on human samples (fig 1). Mol Cancer Res (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:400
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Invitrogen TP53 antibody (Thermo Fisher Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:400. Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen TP53 antibody (LabVisio, DO-7) was used in immunohistochemistry - paraffin section on human samples . APMIS (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen TP53 antibody (LabVision, DO-7) was used in immunohistochemistry on human samples at 1:50. Arch Dermatol Res (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:250
Invitrogen TP53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:250. Am J Clin Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer, Invitrogen TP53 antibody (Zymed, DO-7) was used in immunohistochemistry on human samples . Cancer Biol Med (2012) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; 1:200; fig 1
  • western blot; human; 1:1000; fig 2
In order to analyze the activity of p53 after stimulation with p53-dependent and -independent DNA damaging agents during human herpesvirus-infection, Invitrogen TP53 antibody (Life Technologies, DO-7) was used in immunocytochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; tbl 3
In order to study the expression of Ki-67, tumor protein P53, P21, and P27 in 8 paired WHO grade II astrocytoma samples, Invitrogen TP53 antibody (Zymed, Do-7) was used in immunohistochemistry - paraffin section on human samples (tbl 3). Chin J Cancer (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:30
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen TP53 antibody (Lab Vision, MS-186) was used in immunohistochemistry - paraffin section on human samples at 1:30. Int J Oncol (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the roles of p53 and hMSH2 proteins in oral squamous cell carcinoma and oral dysplastic lesions, Invitrogen TP53 antibody (Zymed, Do7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oral Oncol (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8
In order to assess antibodies to use for the diagnosis of metastatic adenocarcinomas, Invitrogen TP53 antibody (ZYMED, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8). Diagn Cytopathol (2011) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to examine apoptosis and cell proliferation in synovial sarcoma, Invitrogen TP53 antibody (Zymed, D07) was used in immunohistochemistry - paraffin section on human samples . Eur J Cancer Prev (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to discuss recurrent intracranial hemangiopericytoma with multiple metastases, Invitrogen TP53 antibody (Zymed Laboratories, do-7) was used in immunohistochemistry on human samples at 1:50. Chin Med J (Engl) (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to test if Ki-67, proliferating cell nuclear antigen, silver-staining nucleolar organizer regions and p53 could differentiate spontaneous abortions from subtypes of gestational trophoblastic diseases, Invitrogen TP53 antibody (Zymed Laboratories, clone DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Am J Obstet Gynecol (2001) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology TP53 antibody (CST, 2528) was used in western blot on human samples at 1:1000 (fig 7a). Onco Targets Ther (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology TP53 antibody (Cell Signaling, 2528) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
Cell Signaling Technology TP53 antibody (CST, 2528) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
Articles Reviewed
  1. Zhou W, Xu Y, Zhang J, Zhang P, Yao Z, Yan Z, et al. MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma. Leukemia. 2022;36:1861-1869 pubmed publisher
  2. Nishad R, Mukhi D, Singh A, Motrapu M, Chintala K, Tammineni P, et al. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021;12:342 pubmed publisher
  3. Zhou M, Wang X, Shi Y, Ding Y, Li X, Xie T, et al. Deficiency of ITGAM Attenuates Experimental Abdominal Aortic Aneurysm in Mice. J Am Heart Assoc. 2021;10:e019900 pubmed publisher
  4. Hyro x161 x161 ov xe1 P, Arag xf3 M, Moreno Felici J, Fu X, Mendez Lucas A, Garc xed a Rov xe9 s P, et al. PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner. Cancer Metab. 2021;9:1 pubmed publisher
  5. Wang H, Wan X, Pilch P, Ellisen L, Fried S, Liu L. An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming. elife. 2020;9: pubmed publisher
  6. Cheng X, Zhang Y, Song F, Song F, Gao C, Liang X, et al. URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma. Onco Targets Ther. 2020;13:8011-8025 pubmed publisher
  7. Zhang C, Xie Y, Chen H, Lv L, Yao J, Zhang M, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020;12:1272-1284 pubmed publisher
  8. Zhang X, Du K, Lou Z, Ding K, Zhang F, Zhu J, et al. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells. Int J Biol Sci. 2019;15:1460-1471 pubmed publisher
  9. Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157 pubmed publisher
  10. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  11. Zhang G, Liu Y, Xu L, Sha C, Zhang H, Xu W. Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model. BMC Biotechnol. 2019;19:10 pubmed publisher
  12. Fu J, Yu W, Jiang D. Acidic pH promotes nucleus pulposus cell senescence through activating the p38 MAPK pathway. Biosci Rep. 2018;38: pubmed publisher
  13. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed publisher
  14. Wang Z, Ding Y, Wang X, Lu S, Wang C, He C, et al. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT. Cancer Lett. 2018;428:21-33 pubmed publisher
  15. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed publisher
  16. Yang X, Ding Y, Yang M, Yu L, Hu Y, Deng Y. Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5. Kidney Blood Press Res. 2018;43:616-627 pubmed publisher
  17. Shin C, Lee M, Han J, Jeong S, Ryu B, Chi S. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017;114:5683-5688 pubmed publisher
  18. Jang M, Kim S, Hwang D, Kim W, Lim S, Kim W, et al. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. J Korean Med Sci. 2017;32:38-46 pubmed publisher
  19. Bauer M, Joerger A, Fersht A. 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells. Proc Natl Acad Sci U S A. 2016;113:E5271-80 pubmed publisher
  20. Guerra E, Cimadamore A, Simeone P, Vacca G, Lattanzio R, Botti G, et al. p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading. BMC Cancer. 2016;16:649 pubmed publisher
  21. Oktay Y, Ãœlgen E, Can Ã, Akyerli C, Yüksel Å, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6:27569 pubmed publisher
  22. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  23. Nooij L, Dreef E, Smit V, van Poelgeest M, Bosse T. Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions. J Clin Pathol. 2016;69:1070-1075 pubmed publisher
  24. Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli C, et al. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Virchows Arch. 2016;469:61-9 pubmed publisher
  25. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  26. Zheng F, Yue C, Li G, He B, Cheng W, Wang X, et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016;7:10180 pubmed publisher
  27. Cubillos Rojas M, Schneider T, Sánchez Tena S, Bartrons R, Ventura F, Rosa J. Tris-acetate polyacrylamide gradient gel electrophoresis for the analysis of protein oligomerization. Anal Bioanal Chem. 2016;408:1715-9 pubmed publisher
  28. Kramer H, Lai C, Patel H, Periyasamy M, Lin M, Feller S, et al. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res. 2016;44:582-94 pubmed publisher
  29. Domínguez D, Feijoo P, Bernal A, Ercilla A, Agell N, Genescà A, et al. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. Oncotarget. 2015;6:28238-56 pubmed publisher
  30. De Cesare M, Cominetti D, Doldi V, Lopergolo A, Deraco M, Gandellini P, et al. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget. 2015;6:13119-32 pubmed
  31. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome. Pathol Res Pract. 2015;211:505-12 pubmed publisher
  32. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  33. Balboni A, Cherukuri P, Ung M, DeCastro A, Cheng C, DiRenzo J. p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals. Mol Cancer Res. 2015;13:732-42 pubmed publisher
  34. Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed publisher
  35. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  36. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  37. Mingels M, Masadah R, Geels Y, Otte Holler I, de Kievit I, van der Laak J, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol. 2014;142:213-21 pubmed publisher
  38. Basak K, Doguc D, Aylak F, Karadayi N, Gultekin F. Effects of maternally exposed food coloring additives on laryngeal histology in rats. J Environ Pathol Toxicol Oncol. 2014;33:123-30 pubmed
  39. Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed publisher
  40. Kofod Olsen E, Møller J, Schleimann M, Bundgaard B, Bak R, Øster B, et al. Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B. PLoS ONE. 2013;8:e59223 pubmed publisher
  41. Yue W, Sai K, Wu Q, Xia Y, Yu S, Chen Z. Long-term molecular changes in WHO grade II astrocytomas following radiotherapy. Chin J Cancer. 2012;31:159-65 pubmed publisher
  42. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  43. Helal T, Fadel M, El Thobbani A, El Sarhi A. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors. Oral Oncol. 2012;48:120-4 pubmed publisher
  44. Su X, Li G, Liu W, Xie B, Jiang Y. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol. 2011;39:900-8 pubmed publisher
  45. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev. 2006;15:258-65 pubmed
  46. Cao Y, Zhang M, Wang J, Zhang W, Li G, Zhao J. Recurrent intracranial hemangiopericytoma with multiple metastases. Chin Med J (Engl). 2006;119:169-73 pubmed
  47. Kale A, Soylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol. 2001;184:567-74 pubmed